Abatacept (CTLA-4-Ig), a selective costimulation modulator currently used in autoimmune diseases that functions by blocking T cell activation, shows potential for application in epilepsy cases characterized by immune dysregulation. The gene discussed is CTLA4; the disease is epilepsy.